Lymph/Axis is developing new technologies to treat critical diseases such as heart failure, HIV and sepsis by acting on lymphatic fluid.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free